Suppr超能文献

威尔姆斯瘤基因WT1:其致癌功能及临床应用

Wilms' tumor gene WT1: its oncogenic function and clinical application.

作者信息

Sugiyama H

机构信息

Department of Clinical Laboratory Science, Osaka University Medical School, Japan.

出版信息

Int J Hematol. 2001 Feb;73(2):177-87. doi: 10.1007/BF02981935.

Abstract

The Wilms' tumor gene WT1 is a gene responsible for the childhood renal tumor. Wilms' tumor, and is defined as a tumor suppressor gene. However, the wild-type WT1 gene is highly expressed in leukemic blast cells of myeloid and lymphoid origin, and thus, WT1 messenger RNA provides a novel tumor marker for detection of minimal residual disease of leukemias and for monitoring disease progression of myelodysplastic syndromes. The WT1 gene exerts an oncogenic function rather than a tumor-suppressor gene function in solid tumors as well as leukemias, and the WT1 gene product is an attractive tumor antigen capable of eliciting cytotoxic T lymphocytes against WT1-expressing tumors.

摘要

威尔姆斯瘤基因WT1是一种与儿童肾肿瘤——威尔姆斯瘤相关的基因,被定义为肿瘤抑制基因。然而,野生型WT1基因在髓系和淋巴系来源的白血病原始细胞中高表达,因此,WT1信使核糖核酸为检测白血病微小残留病以及监测骨髓增生异常综合征的疾病进展提供了一种新的肿瘤标志物。WT1基因在实体瘤和白血病中发挥致癌功能而非肿瘤抑制基因功能,并且WT1基因产物是一种有吸引力的肿瘤抗原,能够引发针对表达WT1的肿瘤的细胞毒性T淋巴细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验